A citation-based method for searching scientific literature

Neetu Tripathi, Neeraj Tripathi, Manoj Kumar Goshisht. Mol Divers 2022
Times Cited: 8







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
50

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
37

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.
Lifeng Fu, Fei Ye, Yong Feng, Feng Yu, Qisheng Wang, Yan Wu, Cheng Zhao, Huan Sun, Baoying Huang, Peihua Niu,[...]. Nat Commun 2020
190
37

COVID-19: Drug Targets and Potential Treatments.
Carmen Gil, Tiziana Ginex, Inés Maestro, Vanesa Nozal, Lucía Barrado-Gil, Miguel Ángel Cuesta-Geijo, Jesús Urquiza, David Ramírez, Covadonga Alonso, Nuria E Campillo,[...]. J Med Chem 2020
185
37

COVID-19: Characteristics and Therapeutics.
Rameswari Chilamakuri, Saurabh Agarwal. Cells 2021
58
37


Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase.
Rameez Jabeer Khan, Rajat Kumar Jha, Gizachew Muluneh Amera, Monika Jain, Ekampreet Singh, Amita Pathak, Rashmi Prabha Singh, Jayaraman Muthukumaran, Amit Kumar Singh. J Biomol Struct Dyn 2021
185
25


Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
Canrong Wu, Yang Liu, Yueying Yang, Peng Zhang, Wu Zhong, Yali Wang, Qiqi Wang, Yang Xu, Mingxue Li, Xingzhou Li,[...]. Acta Pharm Sin B 2020
25

Diet and Immune Function.
Caroline E Childs, Philip C Calder, Elizabeth A Miles. Nutrients 2019
116
25

Understanding the Roles of the "Two QSARs".
Toshio Fujita, David A Winkler. J Chem Inf Model 2016
64
25


Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study.
Vijay H Masand, Siddhartha Akasapu, Ajaykumar Gandhi, Vesna Rastija, Meghshyam K Patil. Chemometr Intell Lab Syst 2020
6
33

Open Babel: An open chemical toolbox.
Noel M O'Boyle, Michael Banck, Craig A James, Chris Morley, Tim Vandermeersch, Geoffrey R Hutchison. J Cheminform 2011
25

COVID19 - Computational Chemists Meet the Moment.
Adrian J Mulholland, Rommie E Amaro. J Chem Inf Model 2020
8
25

The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities.
Samuel Genheden, Ulf Ryde. Expert Opin Drug Discov 2015
25


α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment.
Linlin Zhang, Daizong Lin, Yuri Kusov, Yong Nian, Qingjun Ma, Jiang Wang, Albrecht von Brunn, Pieter Leyssen, Kristina Lanko, Johan Neyts,[...]. J Med Chem 2020
259
25

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Sangeun Jeon, Meehyun Ko, Jihye Lee, Inhee Choi, Soo Young Byun, Soonju Park, David Shum, Seungtaek Kim. Antimicrob Agents Chemother 2020
345
25

Protein mixtures of environmentally friendly zein to understand protein-protein interactions through biomaterials synthesis, hemolysis, and their antimicrobial activities.
Aabroo Mahal, Manoj Kumar Goshisht, Poonam Khullar, Harsh Kumar, Narinder Singh, Gurinder Kaur, Mandeep Singh Bakshi. Phys Chem Chem Phys 2014
9
25

Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.
Meehyun Ko, Sangeun Jeon, Wang-Shick Ryu, Seungtaek Kim. J Med Virol 2021
49
12


Computer Aided Drug Design: Success and Limitations.
Mohammad Hassan Baig, Khurshid Ahmad, Sudeep Roy, Jalaluddin Mohammad Ashraf, Mohd Adil, Mohammad Haris Siddiqui, Saif Khan, Mohammad Amjad Kamal, Ivo Provazník, Inho Choi. Curr Pharm Des 2016
113
12

QSARINS-chem: Insubria datasets and new QSAR/QSPR models for environmental pollutants in QSARINS.
Paola Gramatica, Stefano Cassani, Nicola Chirico. J Comput Chem 2014
138
12

Repositioning of 8565 Existing Drugs for COVID-19.
Kaifu Gao, Duc Duy Nguyen, Jiahui Chen, Rui Wang, Guo-Wei Wei. J Phys Chem Lett 2020
45
12

Quinoxalinones Based Aldose Reductase Inhibitors: 2D and 3D-QSAR Analysis.
Vijay H Masand, Nahed N Elsayed, Sumersingh D Thakur, Nandkishor Gawhale, Mithilesh M Rathore. Mol Inform 2019
5
20

Severe acute respiratory syndrome.
J S M Peiris, Y Guan, K Y Yuen. Nat Med 2004
612
12

Inhibition of SARS-CoV 3CL protease by flavonoids.
Seri Jo, Suwon Kim, Dong Hae Shin, Mi-Sun Kim. J Enzyme Inhib Med Chem 2020
292
12

Ligand-based approach for predicting drug targets and for virtual screening against COVID-19.
Yanqing Yang, Zhengdan Zhu, Xiaoyu Wang, Xinben Zhang, Kaijie Mu, Yulong Shi, Cheng Peng, Zhijian Xu, Weiliang Zhu. Brief Bioinform 2021
13
12

An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
Thanigaimalai Pillaiyar, Manoj Manickam, Vigneshwaran Namasivayam, Yoshio Hayashi, Sang-Hun Jung. J Med Chem 2016
347
12

QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitors.
V H Masand, N N E El-Sayed, D T Mahajan, V Rastija. SAR QSAR Environ Res 2017
7
14

FlexAID: Revisiting Docking on Non-Native-Complex Structures.
Francis Gaudreault, Rafael J Najmanovich. J Chem Inf Model 2015
21
12

New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors.
Thomas Regnier, Diganta Sarma, Koushi Hidaka, Usman Bacha, Ernesto Freire, Yoshio Hayashi, Yoshiaki Kiso. Bioorg Med Chem Lett 2009
34
12

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery.
Bruno J Neves, Rodolpho C Braga, Cleber C Melo-Filho, José Teófilo Moreira-Filho, Eugene N Muratov, Carolina Horta Andrade. Front Pharmacol 2018
100
12

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety.
Sho Konno, Pillaiyar Thanigaimalai, Takehito Yamamoto, Kiyohiko Nakada, Rie Kakiuchi, Kentaro Takayama, Yuri Yamazaki, Fumika Yakushiji, Kenichi Akaji, Yoshiaki Kiso,[...]. Bioorg Med Chem 2013
38
12


NRGsuite: a PyMOL plugin to perform docking simulations in real time using FlexAID.
Francis Gaudreault, Louis-Philippe Morency, Rafael J Najmanovich. Bioinformatics 2015
32
12

Role of computer-aided drug design in modern drug discovery.
Stephani Joy Y Macalino, Vijayakumar Gosu, Sunhye Hong, Sun Choi. Arch Pharm Res 2015
175
12

Recent discovery and development of inhibitors targeting coronaviruses.
Thanigaimalai Pillaiyar, Sangeetha Meenakshisundaram, Manoj Manickam. Drug Discov Today 2020
183
12

Apparent activity in high-throughput screening: origins of compound-dependent assay interference.
Natasha Thorne, Douglas S Auld, James Inglese. Curr Opin Chem Biol 2010
282
12

Stereochemistry of polypeptide chain configurations.
G N RAMACHANDRAN, C RAMAKRISHNAN, V SASISEKHARAN. J Mol Biol 1963
12

Comparison of MLR, PLS and GA-MLR in QSAR analysis.
A K Saxena, P Prathipati. SAR QSAR Environ Res 2003
42
12

Respiratory virus shedding in exhaled breath and efficacy of face masks.
Nancy H L Leung, Daniel K W Chu, Eunice Y C Shiu, Kwok-Hung Chan, James J McDevitt, Benien J P Hau, Hui-Ling Yen, Yuguo Li, Dennis K M Ip, J S Malik Peiris,[...]. Nat Med 2020
943
12

Coronaviruses - drug discovery and therapeutic options.
Alimuddin Zumla, Jasper F W Chan, Esam I Azhar, David S C Hui, Kwok-Yung Yuen. Nat Rev Drug Discov 2016
910
12

Modelling Chemical Reasoning to Predict and Invent Reactions.
Marwin H S Segler, Mark P Waller. Chemistry 2017
74
12

Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.
Duncan E Scott, Andrew R Bayly, Chris Abell, John Skidmore. Nat Rev Drug Discov 2016
494
12

Artificial intelligence in drug design.
Feisheng Zhong, Jing Xing, Xutong Li, Xiaohong Liu, Zunyun Fu, Zhaoping Xiong, Dong Lu, Xiaolong Wu, Jihui Zhao, Xiaoqin Tan,[...]. Sci China Life Sci 2018
45
12

Multi-task learning models for predicting active compounds.
Zhili Zhao, Jian Qin, Zhuoyue Gou, Yanan Zhang, Yi Yang. J Biomed Inform 2020
2
50

Organic synthesis: The robo-chemist.
Mark Peplow. Nature 2014
32
12



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.